Reid Robison, MD MBA 7/22/21 Reid Robison, MD MBA 7/22/21

Bezinga: Canadian insurance provider to cover off-label use of ketamine for treating depression

Reid Robison, MD MBA 7/19/21 Reid Robison, MD MBA 7/19/21

Truffle Report: Ketamine therapy & addiction risk management

Reid Robison, MD MBA 7/15/21 Reid Robison, MD MBA 7/15/21

Reid Robison, MD MBA 7/5/21 Reid Robison, MD MBA 7/5/21

Reid Robison, MD MBA 6/11/21 Reid Robison, MD MBA 6/11/21

Reid Robison, MD MBA 5/13/21 Reid Robison, MD MBA 5/13/21

Reid Robison, MD MBA 5/13/21 Reid Robison, MD MBA 5/13/21

Reid Robison, MD MBA 4/20/21 Reid Robison, MD MBA 4/20/21

Reid Robison, MD MBA 4/19/21 Reid Robison, MD MBA 4/19/21

Reid Robison, MD MBA 1/31/21 Reid Robison, MD MBA 1/31/21

Reid Robison, MD MBA 1/23/21 Reid Robison, MD MBA 1/23/21

Reid Robison, MD MBA 11/23/20 Reid Robison, MD MBA 11/23/20

Reid Robison, MD MBA 8/4/20 Reid Robison, MD MBA 8/4/20

Reid Robison, MD MBA 6/18/20 Reid Robison, MD MBA 6/18/20

Reid Robison, MD MBA 3/25/20 Reid Robison, MD MBA 3/25/20

Reid Robison, MD MBA 2/10/20 Reid Robison, MD MBA 2/10/20